Skip to main content
STLN logo

STLN · Starling Oncology, Inc. · Analyst Estimates

Track STLN — free
$6.35 +0.14 (+2.17%) At close · Oct 2
Market Cap
$678.76M
Shares
101.92M
Volume · Oct 2 793.88K Avg daily vol (3M) 1.58M

Analyst Estimates

Compare analyst forecasts for Starling Oncology, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 20:45 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.21
-0.162
-0.11
—
-0.138
-0.15
-0.138
-0.145
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
4
4
0
0
Revenue
USD
Publication date not stated
659923000
665013000
669500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06
0.0
0.1
—
-0.025
-0.08
-0.025
-0.09
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
1
1
3
3
Revenue
USD
Publication date not stated
855953000
883967250
915400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.07
-0.048
-0.04
—
-0.036
-0.045
-0.036
-0.04
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
2
2
0
0
Revenue
USD
Publication date not stated
164935000
168692000
171633000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.04
-0.012
0.03
—
-0.016
-0.0175
-0.016
-0.02
— — — —
EPS
analysts
Publication date not stated
— — —
5
— — — —
0
0
2
2
Revenue
USD
Publication date not stated
185172000
187659000
190800000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1799191 CUSIP 68236X100 13F (30d) 2 filings 2 filers Visit website Investor relations